http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2218173-C1

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-095
filingDate 2002-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2003-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef77afad291cea900284c264d96bfdbb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41350866983b614bc68b48b9fc9e496a
publicationDate 2003-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2218173-C1
titleOfInvention Method for alleviating abstinence syndrome, pathological attraction and preventing recidivation in the cases of cocaine narcotic addiction
abstract FIELD: medicine. SUBSTANCE: method involves administering Oxytocin at a dose of 20-30 EU in addition to traditional detoxication therapy in combination with psychotropic means four times a day as 20- 30 days long course. EFFECT: enhanced effectiveness of treatment; no adverse side effects and getting accustomed.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013085106-A1
priorityDate 2002-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446220
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439302
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507320
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3559
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100152272
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID644017
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503740
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507876
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25504
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID38288
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68870
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID18429
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4813803
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416053110
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491026
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID352920
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3386
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3916
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5020
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID280888
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501289
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414857246
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507434
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311507

Total number of triples: 37.